发明公开
EP2604611A1 N-Biaryl substituted diazabicycloalkane derivatives as agonists of the alpha7 and alpha4beta2 nACh Receptor
审中-公开
N-Biarylsubstituierte Diazabicycloalkanderivate als alpha7 und alpha4beta2 nACh Rezeptor Agonisten
- 专利标题: N-Biaryl substituted diazabicycloalkane derivatives as agonists of the alpha7 and alpha4beta2 nACh Receptor
- 专利标题(中): N-Biarylsubstituierte Diazabicycloalkanderivate als alpha7 und alpha4beta2 nACh Rezeptor Agonisten
-
申请号: EP12194563.8申请日: 2008-11-20
-
公开(公告)号: EP2604611A1公开(公告)日: 2013-06-19
- 发明人: JI, Jianguo , LI, Tao , Sippy, Kevin B , Lee, Chih-hung , Gopalakrishnan, Murali
- 申请人: AbbVie Inc.
- 申请人地址: 1 North Waukegan Road North Chicago, IL 60064 US
- 专利权人: AbbVie Inc.
- 当前专利权人: AbbVie Inc.
- 当前专利权人地址: 1 North Waukegan Road North Chicago, IL 60064 US
- 代理机构: Modiano, Micaela Nadia
- 优先权: US989607P 20071121
- 主分类号: C07D487/04
- IPC分类号: C07D487/04 ; A61K31/407 ; A61P25/00
摘要:
The invention relates to biaryl substituted diazabicycloalkanes of formula (I), and more particularly bicycloheteroaryl substituted fused diazabicycloalkane derivatives, compositions comprising such compounds, and such compounds for use for treating or preventing conditions and disorders related to both α7 and α4β2 nAChR activity Formula: (I).
信息查询